fda ends semaglutide shortage Ends: What Patients Need to Know FDA Announces End to Shortage

Transportation safety is guaranteed

Mild digestive discomfort may occur in rare cases if taken in excessive amounts

Herbalife does not endorse or sponsor any weight-loss drugs, including GLP-1s

President for declaring war on chronic disease in this country

Important Safety Information Do not use AOD-9604 if you: Have active cancer or malignancy (use only under medical supervision with appropriate monitoring) Are pregnant or breastfeeding (safety data lacking in these populations) Have known allergy to growth hormone fragments or peptide compounds Have severe uncontrolled metabolic or cardiovascular disease without medical supervision Common side effects may include: Injection site reactions (mild redness, swelling, or tenderness), occasional mild headaches during initial use, and transient lightheadedness